MIR6831: A Potential Drug Target or Biomarker (G102465499)
MIR6831: A Potential Drug Target or Biomarker
MIR6831 (hsa-miR-6831-5p) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker in various diseases, including cancer. Its unique structure and expression pattern have made it an attractive target for researchers to study, and several studies have investigated its potential role in disease progression.
MIR6831 is a microRNA (miRNA) that is expressed in various tissues and cells throughout the body. It is a part of the hsa-miR family, which consists of 20 members in humans. The hsa-miR family is known for its ability to regulate gene expression and contribute to various cellular processes, including cell growth, apoptosis, and inflammation.
One of the most significant features of MIR6831 is its unique expression pattern. It is expressed in various tissues and cells throughout the body, including the brain, pancreas, and gastrointestinal tract. Its expression is highly specific, with no significant expression in other tissues. This makes it an attractive target for researchers to study and identify its functions in different biological processes.
Several studies have investigated the potential role of MIR6831 in cancer progression. Several studies have shown that MIR6831 is highly expressed in various types of cancer, including breast, lung, and colorectal cancer. It is also associated with cancer stem cells, which are cancer cells that have the ability to promote tumor growth and invasiveness.
One of the most significant findings of these studies is that MIR6831 is involved in the regulation of cancer cell survival. Several studies have shown that MIR6831 can inhibit the growth and survival of cancer cells in cell culture and animal models. This suggests that MIR6831 may be a useful drug target or biomarker for cancer treatment.
Another potential role of MIR6831 is its involvement in the regulation of inflammation. Several studies have shown that MIR6831 is involved in the regulation of inflammatory responses and contributes to the development of various inflammatory diseases, including cancer. This suggests that MIR6831 may be a useful target for the development of new treatments for inflammatory diseases.
MIR6831 is also involved in the regulation of cellular processes that are important for maintaining cellular structure and function. Several studies have shown that MIR6831 is involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. This suggests that MIR6831 may be a useful target for the development of new treatments for diseases that are characterized by disrupted cell adhesion.
In conclusion, MIR6831 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker in various diseases. Its unique structure and expression pattern make it an attractive target for researchers to study, and several studies have shown that it is involved in the regulation of various cellular processes that are important for maintaining cellular structure and function. Further research is needed to fully understand the role of MIR6831 in disease progression and to identify its potential as a drug target or biomarker.
Protein Name: MicroRNA 6831
The "MIR6831 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR6831 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR6832 | MIR6833 | MIR6834 | MIR6836 | MIR6837 | MIR6839 | MIR6840 | MIR6841 | MIR6842 | MIR6843 | MIR6844 | MIR6845 | MIR6846 | MIR6847 | MIR6848 | MIR6849 | MIR6850 | MIR6851 | MIR6852 | MIR6853 | MIR6854 | MIR6855 | MIR6856 | MIR6857 | MIR6858 | MIR6859-1 | MIR6859-2 | MIR6859-3 | MIR6859-4 | MIR6860 | MIR6861 | MIR6862-1 | MIR6862-2 | MIR6863 | MIR6864 | MIR6865 | MIR6866 | MIR6867 | MIR6868 | MIR6869 | MIR6870 | MIR6871 | MIR6872 | MIR6873 | MIR6874 | MIR6875 | MIR6876 | MIR6877 | MIR6878 | MIR6879 | MIR6880 | MIR6881 | MIR6882 | MIR6883 | MIR6884 | MIR6885 | MIR6886 | MIR6887 | MIR6888 | MIR6889 | MIR6890 | MIR6891 | MIR6892 | MIR6893 | MIR6894 | MIR6895 | MIR7-1 | MIR7-2 | MIR7-3 | MIR7-3HG | MIR708 | MIR7106 | MIR7107 | MIR7108 | MIR7109 | MIR711 | MIR7110 | MIR7111 | MIR7112 | MIR7113 | MIR7114 | MIR7150 | MIR7151 | MIR7152 | MIR7153 | MIR7154 | MIR7155 | MIR7156 | MIR7158 | MIR7159 | MIR7160 | MIR7161 | MIR7162 | MIR718 | MIR720 | MIR744 | MIR7515 | MIR758 | MIR759 | MIR760
